Skip to main content

AI

By Adam Ang | 03:59 am | September 02, 2022
Also, Lunit has received Taiwan's approval for its AI mammography solution.
By Adam Ang | 06:07 am | September 01, 2022
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
By Adam Ang | 05:02 am | September 01, 2022
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
By Adam Ang | 01:14 am | September 01, 2022
This comes after it launched its CDI tool called DxPrime in June. 
By Emily Olsen | 03:41 pm | August 29, 2022
A review of studies published in npj Digital Medicine found diagnostic and triage accuracy varied but was generally low, raising concerns about using symptom checkers as patient-facing tools.
By Emily Olsen | 11:07 am | August 26, 2022
According to the World Health Organization, breast cancer survival rates vary significantly between different countries.
By Emily Olsen | 01:38 pm | August 25, 2022
Insurance navigator Fair Square Medicare raises $15 million, AI-enabled prostate cancer care startup Avenda Health scores $10 million, and oncology clinical trial startup Trial Library emerges from stealth with $5 million.
By Adam Ang | 01:54 am | August 24, 2022
Dozee's sensor-based technology uses AI to track vital parameters.
By Emily Olsen | 02:27 pm | August 23, 2022
Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.
By Emily Olsen | 12:27 pm | August 23, 2022
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.